维普期刊资源整合服务平台（V6.5）

90篇 您的检索式：作者名="GRITZAPIS AD"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Natural killer Lymphocytes: biology development, and function 显示文摘	Papamichail M Perez SA Gritzapis AD	2004	Cancer Immunol Immunother2004，53，3：	1
2	Interactions between human mesenchymal stem cells and natural killer cells显示文摘	Sotiropoulou PA Perez SA Gritzapis AD	2006	Stem Cells2006，24，1：	1
3	Thl and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Thl) and Graves'disease (Th2)显示文摘	Phenekos C Vryonidou A Gritzapis AD	2004	Neuroimmunomodulation2004，11，4：	1
4	Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells 显示文摘	Mamalaki A Kretsovali A at al	2003	Br J Cancer2003，88，8：	1
5	Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy显示文摘	Lekka E Gritzapis AD Perez SA	2010	Cancer Immunol Im- munother2010，59，5：	1
6	Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function 显示文摘	Sotiriadou NN Perez SA Gritzapis AD	2005	Cell Immunol2005，234，1：	1
7	Large scale expansion of CD3(+)CD56(+)lymphocytes capable of lysing autologoustumor cells with cytokine rich supernatants显示文摘	Gritzapis AD Dimitroulopoulos D Paraskevas E	2002	Cancer Immunol Immunother2002，51，：	1
8	Interactions between human mesenchymal stem cells and natural killer cells 显示文摘	Sotiropoulou PA Perez SA Gritzapis AD	2006	Stem Cells2006，24，1：	1
9	HER-2/neu (657-665) represents an immunogenic epitope of HER-2/ neu oncoprotein with potent antitumor properties显示文摘	Gritzapis AD Fridman A Perez SA	2009	Vac-eine2009，28，1：	1
10	Thl and Th2 serum cytokine profiles characterize patients with Hashimoto' s thyroiditis and Graves' disease 显示文摘	Phenekos C Vryonidou A Gritzapis AD	2012	Neuro Immuno Modulation2012，11，4：	1
11	Identification of a novel immunogenic HLA-A * 0201-binding epitope of HER-2/neu with potent antitumor properties显示文摘	Gritzapis AD Voutsas IF Lekka E	2008	J Immu- nol2008，181，1：	1
12	Large scale expansion of CD3^+ CD56^+ lymphocytes capa- ble of lysing autologous tumor cells with cytokine-rich supernatants 显示文摘	Gritzapis AD Dimitroulopoulos D Paraskevas E	2002	Cancer Immunol Immunother2002，51，8：	1
13	Peptide HER2 (776 -788) represents anaturally processed broad MHC class II-restricted T cell epi tope显示文摘	Sotiriadou R Perez SA Gritzapis AD	2001	British J Cancer2001，85，：	1
14	Natural killer lymphocytes:biology, development,and function显示文摘	Papamiehail M Perez SA Gritzapis AD	2004	Cancer Immunol Immunother2004，53，3：	1
15	Immunogenic HER-2/neu peptides as tumor vaccines 显示文摘	Baxevanis CN Sotiriadou NN Gritzapis AD	2006	Cancer Immunol Immunother2006，55，1：	1
16	Immunogenic HER-2/neu peptides as tumor vaccines 显示文摘	Baxevanis CN Sotiriadou NN Gritzapis AD	2006	Cancer Immunol Im- munother2006，55，1：	1
17	Natural killer lymphocytes: biology, development, and function显示文摘	Papamichail M Perez SA Gritzapis AD	2004	Cancer Immunol Immunother2004，53，3：	1
18	Large- scale expansion of CD3(+)CD56(+) lymphoeytes capable of lysing autologous tumor cells with cytokine-rich supernatants 显示文摘	Gritzapis AD Dimitroulopoulos D Paraskevas E	2002	Cancer Immunol Immunother2002，51，8：	1
19	Interactions between human mesenchymal stem cells and natural killer cells显示文摘	SOTIROPOULOU PA PEREZ SA GRITZAPIS AD	2006	Stem Cells2006，24，1：	1
20	Pooled peptides from HER-2/neu overexpressing primary ovarian tumours induce CTL with potent antitumour responses in vitro and in vivo显示文摘	Gritzapis AD Perez SA Baxevanis CN	2005	Br J Cancer2005，92，1：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示